Eton Pharmaceuticals Inc (ETON)
10.75
+0.32
(+3.07%)
USD |
NASDAQ |
Nov 21, 16:00
10.20
-0.55
(-5.12%)
Pre-Market: 08:42
Eton Pharmaceuticals Profit Margin (Quarterly): 6.07% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 6.07% |
| June 30, 2024 | -33.51% |
| March 31, 2024 | -10.18% |
| December 31, 2023 | -30.85% |
| September 30, 2023 | -8.24% |
| June 30, 2023 | 38.00% |
| March 31, 2023 | -50.15% |
| December 31, 2022 | 10.73% |
| September 30, 2022 | -94.59% |
| June 30, 2022 | -21.17% |
| March 31, 2022 | -244.9% |
| December 31, 2021 | 17.05% |
| Date | Value |
|---|---|
| September 30, 2021 | -786.3% |
| June 30, 2021 | -65.73% |
| March 31, 2021 | 43.00% |
| December 31, 2020 | -9.49K% |
| September 30, 2020 | |
| June 30, 2020 | -23.65K% |
| March 31, 2020 | -9.14K% |
| December 31, 2019 | -587.4% |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | -1.48K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-23.65K%
Minimum
Jun 2020
43.00%
Maximum
Mar 2021
-2.32K%
Average
-33.51%
Median
Jun 2024
Profit Margin (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 14.22% |
| Integra Lifesciences Holdings Corp | -2.81% |
| Elutia Inc | 21.72% |
| Immuneering Corp | -- |
| Journey Medical Corp | -16.34% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -35.45% |
| Return on Assets | -16.95% |
| Return on Invested Capital | -26.81% |
| Gross Profit Margin (Quarterly) | 61.04% |
| Operating Margin (Quarterly) | 4.93% |
| Return on Net Operating Assets | -47.15% |